enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/eye-drop-recall-know-113000380.html

   Eye drops are being recalled due to a rare bacterium found in artificial tears. Find a list of recalled drops in 2023. Plus, eye infection symptoms.

3. CDC warns that tainted recalled eyedrops now linked to more ...

   www.aol.com/cdc-warns-tainted-recalled-eyedrops...

   According to the CDC, people should seek medical care if they have symptoms of an eye infection, including: Yellow, green or clear discharge from the eye. Eye pain or discomfort.

4. Natamycin - Wikipedia

   en.wikipedia.org/wiki/Natamycin

   Natamycin, also known as pimaricin, is an antifungal medication used to treat fungal infections around the eye. [1] [2] This includes infections of the eyelids, conjunctiva, and cornea. [1] It is used as eyedrops. [1] Natamycin is also used in the food industry as a preservative. [2] Allergic reactions may occur. [1]

5. Pirenoxine - Wikipedia

   en.wikipedia.org/wiki/Pirenoxine

   Pirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts. A report in the Inorganic Chemistry journal s howed that in liquid solutions, pirenoxine could cause decreased cloudiness of a crystallin solution produced to mimic the environment of the eye.

6. Ophthalmic drug administration - Wikipedia

   en.wikipedia.org/wiki/Ophthalmic_drug_administration

   Figure 1.0 - Basic anatomical features of the human eye. Ophthalmic drug administration is the administration of a drug to the eyes, most typically as an eye drop formulation. Topical formulations are used to combat a multitude of diseased states of the eye. These states may include bacterial infections, eye injury, glaucoma, and dry eye. [1]

7. 2022–2023 United States P. aeruginosa outbreak in eye drops

   en.wikipedia.org/wiki/2022–2023_United_States_P...

   The CDC was notified of eye infections among four people at an ophthalmology clinic in California in late June 2022, and received notice of an outbreak at long-term care facilities in Connecticut in late July and Utah in August involving 21 and three people, respectively. [3]